BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19708812)

  • 1. Influenza viruses control the vertebrate type I interferon system: factors, mechanisms, and consequences.
    Wolff T; Ludwig S
    J Interferon Cytokine Res; 2009 Sep; 29(9):549-57. PubMed ID: 19708812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sabotage of antiviral signaling and effectors by influenza viruses.
    Wolff T; Zielecki F; Abt M; Voss D; Semmler I; Matthaei M
    Biol Chem; 2008 Oct; 389(10):1299-305. PubMed ID: 18713015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robust expression of vault RNAs induced by influenza A virus plays a critical role in suppression of PKR-mediated innate immunity.
    Li F; Chen Y; Zhang Z; Ouyang J; Wang Y; Yan R; Huang S; Gao GF; Guo G; Chen JL
    Nucleic Acids Res; 2015 Dec; 43(21):10321-37. PubMed ID: 26490959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Innate Immune Responses by the Influenza A NS1 and PA-X Proteins.
    Nogales A; Martinez-Sobrido L; Topham DJ; DeDiego ML
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30545063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of interferon inducible trans-membrane proteins and retinoic acid inducible gene I for influenza virus replication: A review.
    Suo S; Ren X
    Crit Rev Microbiol; 2016; 42(1):75-82. PubMed ID: 25811941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of evasion of the type I interferon antiviral response by flaviviruses.
    Diamond MS
    J Interferon Cytokine Res; 2009 Sep; 29(9):521-30. PubMed ID: 19694536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Influenza A Virus NS1 Deals with the Ubiquitin System to Evade Innate Immunity.
    Lamotte LA; Tafforeau L
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role of an antiviral stress granule containing RIG-I and PKR in viral detection and innate immunity.
    Onomoto K; Jogi M; Yoo JS; Narita R; Morimoto S; Takemura A; Sambhara S; Kawaguchi A; Osari S; Nagata K; Matsumiya T; Namiki H; Yoneyama M; Fujita T
    PLoS One; 2012; 7(8):e43031. PubMed ID: 22912779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual Effect of Organogermanium Compound THGP on RIG-I-Mediated Viral Sensing and Viral Replication during Influenza a Virus Infection.
    Baidya S; Nishimoto Y; Sato S; Shimada Y; Sakurai N; Nonaka H; Noguchi K; Kido M; Tadano S; Ishikawa K; Li K; Okubo A; Yamada T; Orba Y; Sasaki M; Sawa H; Miyamoto H; Takada A; Nakamura T; Takaoka A
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influenza viruses and intracellular signalling pathways].
    Planz O
    Berl Munch Tierarztl Wochenschr; 2006; 119(3-4):101-11. PubMed ID: 16573200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay between influenza A virus and the innate immune signaling.
    Ehrhardt C; Seyer R; Hrincius ER; Eierhoff T; Wolff T; Ludwig S
    Microbes Infect; 2010 Jan; 12(1):81-7. PubMed ID: 19782761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viruses and interferon: a fight for supremacy.
    Katze MG; He Y; Gale M
    Nat Rev Immunol; 2002 Sep; 2(9):675-87. PubMed ID: 12209136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chicken interferons, their receptors and interferon-stimulated genes.
    Goossens KE; Ward AC; Lowenthal JW; Bean AG
    Dev Comp Immunol; 2013 Nov; 41(3):370-6. PubMed ID: 23751330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alpha/beta interferon receptor provides protection against influenza virus replication but is dispensable for inflammatory response signaling.
    Goodman AG; Zeng H; Proll SC; Peng X; Cillóniz C; Carter VS; Korth MJ; Tumpey TM; Katze MG
    J Virol; 2010 Feb; 84(4):2027-37. PubMed ID: 19939913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions Between NS1 of Influenza A Viruses and Interferon-α/β: Determinants for Vaccine Development.
    Wang BX; Fish EN
    J Interferon Cytokine Res; 2017 Aug; 37(8):331-341. PubMed ID: 28514196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction and evasion of type I interferon responses by influenza viruses.
    García-Sastre A
    Virus Res; 2011 Dec; 162(1-2):12-8. PubMed ID: 22027189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standing on three legs: antiviral activities of RIG-I against influenza viruses.
    Weber-Gerlach M; Weber F
    Curr Opin Immunol; 2016 Oct; 42():71-75. PubMed ID: 27318973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein synthesis shut-off induced by influenza virus infection is independent of PKR activity.
    Zürcher T; Marión RM; Ortín J
    J Virol; 2000 Sep; 74(18):8781-4. PubMed ID: 10954584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectious salmon anemia virus (ISAV) replication is transiently inhibited by Atlantic salmon type I interferon in cell culture.
    Svingerud T; Holand JK; Robertsen B
    Virus Res; 2013 Nov; 177(2):163-70. PubMed ID: 23973914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis.
    Min JY; Li S; Sen GC; Krug RM
    Virology; 2007 Jun; 363(1):236-43. PubMed ID: 17320139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.